In Billing
Oct 28th, 2011
The Oncotype DX® Colon Cancer Assay meets criteria for analytical and clinical validity and clinical utility as a reasonable and necessary Medicare benefit, Palmetto GBA announced after completing a recent assessment. Effective Sept. 18, 2011 the jurisdiction 1 Part B Medicare administrative contractor (J1-B MAC) says it will reimburse Oncotype DX® Colon Cancer Assay services ...
Dec 14th, 2009
Wondering what CPT® 2010 holds in store for laboratory and pathology coding? “From chemistry to surgical pathology, you’ll find new codes in CPT 2010 that you need to know,” Peggy Slagle, CPC, billing compliance coordinator at the University of Nebraska Medical Center in Omaha recently told Pathology/Lab Coding Alert. Fifteen to be precise. In the Chemistry subsection, look ...